According to our research findings, if hs-cTn-I is measured in patients with idiopathic DCM after their diagnosis, it can identify those patients who are at high risk of a poor prognosis and enable more aggressive treatment to improve their prognosis. The gene discussed is TNNI3; the disease is familial dilated cardiomyopathy.